Voloridge Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.23M | Sell |
187,395
-144,248
| -43% | -$4.8M | 0.02% | 692 |
|
2025
Q1 | $9.72M | Buy |
331,643
+131,162
| +65% | +$3.84M | 0.04% | 573 |
|
2024
Q4 | $6.59M | Buy |
200,481
+4,082
| +2% | +$134K | 0.02% | 694 |
|
2024
Q3 | $8.73M | Sell |
196,399
-124,132
| -39% | -$5.52M | 0.03% | 625 |
|
2024
Q2 | $13.8M | Buy |
320,531
+277,318
| +642% | +$12M | 0.05% | 483 |
|
2024
Q1 | $1.26M | Buy |
+43,213
| New | +$1.26M | ﹤0.01% | 941 |
|
2022
Q3 | – | Sell |
-163,784
| Closed | -$3.63M | – | 1371 |
|
2022
Q2 | $3.63M | Sell |
163,784
-16,145
| -9% | -$358K | 0.02% | 793 |
|
2022
Q1 | $5.24M | Buy |
179,929
+134,850
| +299% | +$3.93M | 0.03% | 618 |
|
2021
Q4 | $1.48M | Buy |
45,079
+27,640
| +158% | +$909K | 0.01% | 1162 |
|
2021
Q3 | $805K | Buy |
+17,439
| New | +$805K | 0.01% | 1341 |
|
2021
Q1 | – | Sell |
-15,910
| Closed | -$689K | – | 1353 |
|
2020
Q4 | $689K | Buy |
+15,910
| New | +$689K | 0.01% | 1069 |
|
2020
Q3 | – | Sell |
-7,384
| Closed | -$395K | – | 1221 |
|
2020
Q2 | $395K | Buy |
+7,384
| New | +$395K | ﹤0.01% | 1079 |
|
2019
Q1 | – | Sell |
-36,922
| Closed | -$1.7M | – | 915 |
|
2018
Q4 | $1.7M | Buy |
+36,922
| New | +$1.7M | 0.08% | 213 |
|